Isterian Biotech
Brooklyn, US · Founded 2019 · Delaware corporation
The page presents team members affiliated with Cambrian Bio, describing roles in R&D project management, business operations, and medicinal chemistry consulting within drug discovery and development. The individuals have backgrounds in developing medicines and small-molecule therapeutics across pharma and biotech.
Founders & leadership
JG
James G. PeyerNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2020
▶$3MraisedMay 2020 · 1 investors · BiotechnologyRule 506(b)
▶$3MraisedMay 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James G. PeyerExecutive Officer, Director, Promoter
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlap
Companies competing with Isterian Biotech for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Isterian Biotech do?
- The page presents team members affiliated with Cambrian Bio, describing roles in R&D project management, business operations, and medicinal chemistry consulting within drug discovery and development. The individuals have backgrounds in developing medicines and small-molecule therapeutics across pharma and biotech.
- How much funding has Isterian Biotech raised?
- Isterian Biotech has disclosed $3M raised across 1 round.
- Where is Isterian Biotech headquartered?
- Isterian Biotech is headquartered in Brooklyn, US.